Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
about
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapyRegulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsUrinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype.Proteolytic modification of laminins: functional consequences.Ganoderma lucidum (Reishi) in cancer treatment.Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.Modulation of urokinase plasminogen activator system by poly(ADP-ribose)polymerase-1 inhibition.Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways.Regulation of u-PA gene expression in human prostate cancer.Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells.RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts.ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor.Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells.Priming the seed: alters epithelial cell invasiveness in early gastric carcinogenesis
P2860
Q24597964-B359442F-93D5-4851-BD96-5BD8F7538E8BQ24631327-A27B27A7-5480-48E4-AE16-B546EB116F69Q33675116-23EF7D36-01FC-4A5A-8A18-3AABD7A35969Q33687878-04D66C8D-DCD5-4B3E-9401-9630C88ACF6DQ34071967-0752D4B5-9A9E-43A1-A90D-6C873C8B879CQ35624532-291DF0C7-ECDF-40DD-A46E-D7EA608B267BQ38324229-964D5DDB-6C4B-4193-B2F7-24C5BE30B112Q38932536-68E3DC74-95A0-442F-8C09-F5EDAB485F3AQ40309916-56F2AF8B-7B4D-4959-96AC-9E50A3052488Q40763122-5305288D-558D-4CD9-B5DA-3DDB2CF999DBQ40978991-5AB9DEC9-D97B-4B8E-8FED-D5B5EB262C47Q42811463-5B270922-AC26-4477-9F33-A835B4299BECQ42823190-E18A7ABD-F1F3-46C1-ADA9-21245ADC4828Q42826479-1A41BB1E-7AEF-4FD1-8C92-55250F23C06CQ43594124-5C8A1C01-932B-4EB1-BA90-1709AD1A0183Q58737385-3779113D-8798-443F-BFDB-D831FC17C58E
P2860
Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Regulation of urokinase-type p ...... mous cell carcinoma cell line.
@en
type
label
Regulation of urokinase-type p ...... mous cell carcinoma cell line.
@en
prefLabel
Regulation of urokinase-type p ...... mous cell carcinoma cell line.
@en
P2093
P2860
P1476
Regulation of urokinase-type p ...... mous cell carcinoma cell line.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-4644(19960601)61:3<430::AID-JCB10>3.0.CO;2-N
P577
1996-06-01T00:00:00Z